Cargando…

Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid

OBJECTIVE—Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wensaas, Andreas J., Rustan, Arild C., Just, Marlene, Berge, Rolf K., Drevon, Christian A., Gaster, Michael
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646050/
https://www.ncbi.nlm.nih.gov/pubmed/19066312
http://dx.doi.org/10.2337/db08-1043
_version_ 1782164813858734080
author Wensaas, Andreas J.
Rustan, Arild C.
Just, Marlene
Berge, Rolf K.
Drevon, Christian A.
Gaster, Michael
author_facet Wensaas, Andreas J.
Rustan, Arild C.
Just, Marlene
Berge, Rolf K.
Drevon, Christian A.
Gaster, Michael
author_sort Wensaas, Andreas J.
collection PubMed
description OBJECTIVE—Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS—We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS—Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of β-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO(2)) and β-oxidation of palmitic acid, whereas EPA increased only β-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO(2) formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS—Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid β-oxidation; 2) EPA promoted accumulation of TAG, enhanced β-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation.
format Text
id pubmed-2646050
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-26460502010-03-01 Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid Wensaas, Andreas J. Rustan, Arild C. Just, Marlene Berge, Rolf K. Drevon, Christian A. Gaster, Michael Diabetes Metabolism OBJECTIVE—Increased availability of fatty acids is important for accumulation of intracellular lipids and development of insulin resistance in human myotubes. It is unknown whether different types of fatty acids like eicosapentaenoic acid (EPA) or tetradecylthioacetic acid (TTA) influence these processes. RESEARCH DESIGN AND METHODS—We examined fatty acid and glucose metabolism and gene expression in cultured human skeletal muscle cells from control and type 2 diabetic individuals after 4 days of preincubation with EPA or TTA. RESULTS—Type 2 diabetes myotubes exhibited reduced formation of CO(2) from palmitic acid (PA), whereas release of β-oxidation products was unchanged at baseline but significantly increased with respect to control myotubes after preincubation with TTA and EPA. Preincubation with TTA enhanced both complete (CO(2)) and β-oxidation of palmitic acid, whereas EPA increased only β-oxidation significantly. EPA markedly enhanced triacylglycerol (TAG) accumulation in myotubes, more pronounced in type 2 diabetes cells. TAG accumulation and fatty acid oxidation were inversely correlated only after EPA preincubation, and total level of acyl-CoA was reduced. Glucose oxidation (CO(2) formation) was enhanced and lactate production decreased after chronic exposure to EPA and TTA, whereas glucose uptake and storage were unchanged. EPA and especially TTA increased the expression of genes involved in fatty acid uptake, activation, accumulation, and oxidation. CONCLUSIONS—Our results suggest that 1) mitochondrial dysfunction in diabetic myotubes is caused by disturbances downstream of fatty acid β-oxidation; 2) EPA promoted accumulation of TAG, enhanced β-oxidation, and increased glucose oxidation; and 3) TTA improved complete palmitic acid oxidation in diabetic myotubes, opposed increased lipid accumulation, and increased glucose oxidation. American Diabetes Association 2009-03 /pmc/articles/PMC2646050/ /pubmed/19066312 http://dx.doi.org/10.2337/db08-1043 Text en Copyright © 2009, American Diabetes Association Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Metabolism
Wensaas, Andreas J.
Rustan, Arild C.
Just, Marlene
Berge, Rolf K.
Drevon, Christian A.
Gaster, Michael
Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
title Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
title_full Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
title_fullStr Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
title_full_unstemmed Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
title_short Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of β-Oxidation Products Because of Impaired Fatty Acid Oxidation: Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid
title_sort fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of β-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid
topic Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646050/
https://www.ncbi.nlm.nih.gov/pubmed/19066312
http://dx.doi.org/10.2337/db08-1043
work_keys_str_mv AT wensaasandreasj fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid
AT rustanarildc fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid
AT justmarlene fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid
AT bergerolfk fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid
AT drevonchristiana fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid
AT gastermichael fattyacidincubationofmyotubesfromhumanswithtype2diabetesleadstoenhancedreleaseofboxidationproductsbecauseofimpairedfattyacidoxidationeffectsoftetradecylthioaceticacidandeicosapentaenoicacid